High-definition, wide field of view corneal imaging

高清、宽视场角膜成像

基本信息

批准号：
10007064
负责人：
Cristina Canavesi
金额：
$ 79.57万
依托单位：
LIGHTOPTECH CORPORATION
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-09-01 至 2022-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10007064
关键词：
3-Dimensional Address Area Assessment tool Blindness Cell Count Cell Density Cell Survival Cell Viability Process Cellular Morphology Characteristics Clinic Confocal Microscopy Cornea Corneal Diseases Disease Endothelial Cells Evaluation Eye Eye Banks Goals Gold Grant Health Human Image Imaging Device Imaging Techniques Industry Infection Innovation Corps International Lead Legal patent Machine Learning Measurement Measures Methods Microscope Microscopy Monitor Morphology Operative Surgical Procedures Ophthalmology Optics Organ Transplantation Patient imaging Phase Positioning Attribute Process Research Resolution Rights Sampling Sampling Errors Small Business Innovation Research Grant Standardization Structure Technology Thick Thinness Time Tissue Donors Tissue Transplantation Tissues Training Transplantation United States National Institutes of Health Universities Variant Visual Visual impairment Visual system structure Visualization software base clinical development clinical imaging commercial application density image processing improved in vivo in vivo regeneration innovation instrument instrumentation microscopic imaging multidisciplinary neurosensory novel phase 2 study programs prototype screening three-dimensional visualization tool trend

3-Dimensional Address Area Assessment tool Blindness Cell Count Cell Density Cell Survival Cell Viability Process Cellular Morphology Characteristics Clinic Confocal Microscopy Cornea Corneal Diseases Disease Endothelial Cells Evaluation Eye Eye Banks Goals Gold Grant Health Human Image Imaging Device Imaging Techniques Industry Infection Innovation Corps International Lead Legal patent Machine Learning Measurement Measures Methods Microscope Microscopy Monitor Morphology Operative Surgical Procedures Ophthalmology Optics Organ Transplantation Patient imaging Phase Positioning Attribute Process Research Resolution Rights Sampling Sampling Errors Small Business Innovation Research Grant Standardization Structure Technology Thick Thinness Time Tissue Donors Tissue Transplantation Tissues Training Transplantation United States National Institutes of Health Universities Variant Visual Visual impairment Visual system structure Visualization software base clinical development clinical imaging commercial application density image processing improved in vivo in vivo regeneration innovation instrument instrumentation microscopic imaging multidisciplinary neurosensory novel phase 2 study programs prototype screening three-dimensional visualization tool trend

展开

项目摘要

The cornea is the primary focusing structure of our visual system. Infections and diseases in the tissue can impair vision and lead to blindness, even in eyes with intact neurosensory function. Corneal disease is one of the leading causes of visual deficiency and blindness in the world. Tissue evaluation is an important step for assessing the health of the donor cornea and its appropriateness for different types of placement, yet this process suffers from high subjectivity. High-definition corneal imaging is needed to assist in selection of the most appropriate tissue for transplant. Progress on this front would greatly serve public need, as the cornea is the most commonly transplanted tissue worldwide, with nearly 185,000 transplants annually. Thus, a more sensitive and quantitative method for objective evaluation of tissue at eye banks is needed. We have developed a 3D high-definition imaging instrument based on Gabor-Domain Optical Coherence Microscopy (GDOCM). Our SBIR Phase I research successfully accomplished all Aims and demonstrated the feasibility of quantitative assessment of corneal tissue over a large field of view with GDOCM. Our Phase I results demonstrated that GDOCM has the following key advantages over existing corneal imaging techniques, which include specular and confocal microscopy: 1) improved accuracy of tissue qualification with 4-10x increase in field of view that reduces sampling error – this will provides a truer assessment of the overall tissue characteristics; 2) ability to simultaneously measure corneal thickness, quantify endothelial cell density, and identify morphological variations due to corneal disease – this will lead to complete corneal evaluation in a single instrument; 3) leveraging machine learning innovations to minimize variability induced by users – this will result in a more objective evaluation; 4) enhanced 3D cellular-level imaging of thin translucent endothelial cells – this will enable a detailed understanding of cell viability. The results of the proposed Phase studies II will demonstrate that GDOCM can provide high-definition, 3D visualization of corneal structures with immediate commercial application for qualification of donor tissue in eye banks, and with a path to in vivo clinical imaging of patients with corneal disease.

角膜是我们视觉系统的主要聚焦结构。组织中的感染和疾病可以即使在具有完整的神经感觉功能的眼睛中，也会损害视力并导致失明。角膜疾病是世界上视觉缺乏和失明的主要原因。组织评估是重要的一步评估捐赠者角膜的健康及其对不同类型的安置的适当性，但这是过程遭受高主观性。需要高清角膜成像以帮助选择最合适的组织用于移植。在这方面的进步将极大地满足公众需求，因为角膜是全世界最常见的组织最常移植组织，每年将接近185,000个移植。那，更多需要对眼库的组织客观评估的敏感和定量方法。我们已经开发了一种基于Gabor域光学连贯性的3D高清成像仪器显微镜（GDOCM）。我们的SBIR阶段研究成功完成了所有目标，并证明了用GDOCM在大型视野上对角膜组织进行定量评估的可行性。我们的阶段结果证明GDOCM比现有角膜成像技术具有以下关键优势，包括特定和共聚焦显微镜：1）提高组织资格的准确性，增加了4-10倍减少采样误差的视野 - 这将提供对整个组织的真实评估特征; 2）能够同时测量角膜厚度，量化内皮细胞密度和确定由于角膜疾病引起的形态变化 - 这将导致单一的角膜评估乐器; 3）利用机器学习创新以最大程度地减少用户引起的可变性 - 这将导致在更客观的评估中； 4）增强了薄半透明内皮细胞的3D细胞水平成像 - 这将对细胞活力有详细的了解。提出的阶段研究结果II将证明GDOCM可以提供高清，3D 具有立即商业应用的角膜结构的可视化供体组织在眼睛中的资格银行，并具有角膜疾病患者体内临床成像的途径。